Key Metrics
CiteScore 

4.5
Eigenfactor 

0.001 - 0.005
Impact Factor 

< 5
SJR 

Q2Pharmacology

SNIP 

0.79
Recommended pre-submission checks
Powered by 

Topics Covered on Drug Metabolism and Pharmacokinetics
Drug Metabolism and Pharmacokinetics Journal Specifications
| Overview | |
| Publisher | JAPANESE SOC STUDY XENOBIOTICS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1986 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Drug Metabolism and Pharmacokinetics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Drug Metabolism and Pharmacokinetics
Advances in In silico predictive models for DDI prediction: Implications and practical applications in drug discovery.
- 1 Jun 2026
- Drug metabolism and pharmacokinetics
Advances in DDI evaluations: Recent trends from pre-clinical studies to regulatory submissions.
- 1 Jun 2026
- Drug metabolism and pharmacokinetics
N6-methyladenosine modification of MRP7 mRNA modulates its expression and paclitaxel sensitivity in lung cancer-derived A549cells.
- 1 Jun 2026
- Drug metabolism and pharmacokinetics
Glutathione-reversible inactivation of aldehyde oxidase by hydralazine contributes to inter-lot inhibition variability in human hepatocytes.
- 1 Jun 2026
- Drug metabolism and pharmacokinetics
Regulatory impact of G-quadruplexes in the human carboxylesterase 2 gene on drug and lipid metabolism.
- 1 Jun 2026
- Drug metabolism and pharmacokinetics
Points to consider in the in vitro estimation of kinetic parameters for quantitative prediction of the drug-drug interactions caused by reversible inhibition of enzymes/transporters.
- 1 Jun 2026
- Drug metabolism and pharmacokinetics
Advances in In silico predictive models for DDI prediction: Implications and practical applications in drug discovery.
- 1 Jun 2026
- Drug metabolism and pharmacokinetics
Advances in DDI evaluations: Recent trends from pre-clinical studies to regulatory submissions.
- 1 Jun 2026
- Drug metabolism and pharmacokinetics
N6-methyladenosine modification of MRP7 mRNA modulates its expression and paclitaxel sensitivity in lung cancer-derived A549cells.
- 1 Jun 2026
- Drug metabolism and pharmacokinetics
Glutathione-reversible inactivation of aldehyde oxidase by hydralazine contributes to inter-lot inhibition variability in human hepatocytes.
- 1 Jun 2026
- Drug metabolism and pharmacokinetics
Regulatory impact of G-quadruplexes in the human carboxylesterase 2 gene on drug and lipid metabolism.
- 1 Jun 2026
- Drug metabolism and pharmacokinetics
Points to consider in the in vitro estimation of kinetic parameters for quantitative prediction of the drug-drug interactions caused by reversible inhibition of enzymes/transporters.
- 1 Jun 2026
- Drug metabolism and pharmacokinetics